Consultation on the Draft Guidance: Public or Canadian Armed Forces Health Emergencies - Drugs for Immediate Use or Stockpiling
From Health Canada
Current status: Closed
This consultation ran from May 10, 2019 to July 19, 2019.
This draft guidance provides information on the interpretation of the proposed amendments to the Food and Drug Regulations (FDR) entitled "Regulations Amending Certain Regulations Concerning the Sale of Drugs (Public or Canadian Armed Forces Health Emergencies)". It also assists public health officials to comply with the proposed regulatory requirements by explaining the application process when requesting a drug for use in a public or military health emergency, as well as reporting, record keeping and drug labelling requirements.
Join in: how to participate
Send us an email:
Send an email to HC.Policy.Bureau.Enquiries.SC@canada.ca with your ideas or comments to make yourself heard.
Participate by mail:
Send a letter with your ideas and input to the address in contact information below.
Who is the focus of this consultation?
We will engage with:
- Chief Medical Officers of Health of Federal, Provincial, Territorial jurisdictions
- Municipal Medical Officers of Health
- Surgeon General of the Canadian Armed Forces
- Drug Manufacturers
- General Public
Goals of the consultation
We are seeking stakeholder comments on the draft guidance. This draft guidance should be read in conjunction with the proposed regulations posted on the Canada Gazette website website. The input gathered through this consultation will be used to finalize the guidance document.
- Pre-publication of draft regulations in Canada Gazette I
Bureau of Policy, Science, and International Programs (BPSIP)
Therapeutic Products Directorate
Health Products and Food Branch
Holland Cross, Tower B
1600 Scott St
Address Locator: 3102C1
- Date modified: